Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLL
for Chronic Lymphocytic Leukemia
Drug: Sonrotoclax
2 locations incl. Boston
Sponsor: Massachusetts General Hospital
Sex: All·Age: 18+
Code: NCT06849713·Phase 2·Recruiting